arginine has been researched along with fluorouracil in 55 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 25 (45.45) | 18.7374 |
| 1990's | 5 (9.09) | 18.2507 |
| 2000's | 6 (10.91) | 29.6817 |
| 2010's | 17 (30.91) | 24.3611 |
| 2020's | 2 (3.64) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Fast, R | 1 |
| Donald, PJ | 1 |
| Rumack, BH; Smolinske, SC; Spoerke, DG; Wruk, KM | 1 |
| Cowden, RR; Markert, CL | 1 |
| Ofengand, J | 1 |
| Guir, J; Obert, G; Tripier, F | 1 |
| Altera, KP; Moulton, JE | 1 |
| Barner, HD; Cohen, SS; Stern, JL | 1 |
| Mohberg, J; Rusch, HP | 1 |
| Coffey, JJ | 1 |
| Jiang, J; Liu, J; Yang, C; Zhang, A; Zhu, J | 1 |
| Adamiak, RW; Bielecki, L; Fischer, A; Gdaniec, Z; Grabarkiewicz, T; Olejniczak, M | 1 |
| SOFFER, RL | 1 |
| Jiang, JM; Liu, JY; Yin, XY; Zhu, JR | 1 |
| Arndt, MA; Baskerville, C; Battaglia, V; Colombatto, S; Ientile, R; Isome, M; Lortie, MJ; Parisi, E; Pizzo, DP; Satriano, J; Toninello, A | 1 |
| Geater, A; Laohawiriyakamol, S; Pradutkanchana, J; Puttawibul, P; Raungkhajorn, P; Ruangsin, S; Sangthawan, D; Sunpaweravong, P; Sunpaweravong, S | 1 |
| Fujii, C; Fujino, M; Fukunaga, M; Hachino, Y; Hamaguchi, Y; Imamura, H; Iseki, C; Ishizaka, T; Kamigaki, S; Kawabata, R; Kawase, T; Kimura, Y; Yamamoto, E | 1 |
| Abo-Riya, M; Infante, MR; Manresa, MA; Muzzalupo, R; Pérez, L; Pinazo, A; Tavano, L | 1 |
| Alvarez-Leite, JI; Antunes, MM; Cardoso, VN; Correia, MI; Generoso, SV; Leocádio, PC; Leonel, AJ; Machado, DC; Teixeira, LG | 1 |
| Azadbakht, M; Jahani, M; Mansouri, K; Norooznezhad, F | 1 |
| Bhudhisawasdi, V; Li, YY; Navasumrit, P; Parnlob, V; Ruchirawat, M; Savaraj, N; Sricharunrat, T; Thongkum, A; Wangpaichitr, M; Wu, C | 1 |
| Abedi-Valugerdi, M; Hassan, M; Madjidzadeh, K; Shariatpanahi, SP | 1 |
| Al-Aqbi, SS; Alexandrou, C; Andreadi, C; Blades, M; Boyle, W; Brown, K; Cheng, PN; Higgins, JA; Howells, LM; Karmokar, A; Luo, JL; Moore, DA; Murray, GI; Rufini, A; Thomas, A; Viskaduraki, M | 1 |
| Azadbakht, M; Jahani, M; Mansouri, K; Rasouli, H; Rezazadeh, D; Salari, N; Yarani, R | 1 |
| Chogan, F; Faal Hamedani, N; Ghaemi, A; Haghiralsadat, BF; Javadi, S; Malekimusavi, H; Masoudi, G; Omidi, M; Rashedi, H; Teimouri, M; Yazdian, F | 1 |
| da Silva, KA; da Silva, SBB; de Andrade Bernal Fagiani, M; de Azevedo Mello, F; de Souza Reis, LSL; Fluminhan, A; Giozo, PFI; Gonçalves, GV; Pereira, LG; Santarem, CL; Tsujigushi, LK; Yabuki, D | 1 |
| Bala, A; Panditharadyula, SS | 1 |
| Harada, M; Iida, Y; Ishitobi, K; Kotani, H; Notsu, Y; Tajima, Y; Taniura, T | 1 |
| Andrade, MER; Cardoso, VN; Cassali, GD; Cavalcante, GG; da Silva, TF; de Carvalho Azevedo, VA; de Oliveira Carvalho, RD; de Oliveira, JS; Dos Reis, DC; Fernandes, SOA; Generoso, SV; Leite, JIA; Leocádio, PCL; Trindade, LM | 1 |
| Baron, A; Blic, V; Garcia-Giralt, E; Gautier, H; Huguenin, P; Jouve, M; Langlois, A; Morin, P; Palangie, T; Pouillart, P; Regensberg, C | 1 |
| Beck, H; Capranico, G; Gazdar, AF; Giaccone, G; Zunino, F | 1 |
| Weiss, RB | 1 |
| Chrétien, P; Huot, J; Lambert, H; Landry, J; Roy, G | 1 |
| Carbone, A; Carmignani, G; Dal Bo, V; Francini, M; Lo Re, G; Magri, MD; Merlo, A; Morassut, S; Talamini, R; Veronesi, A | 1 |
| Bezwoda, WR; Derman, DP; Kew, M; Weaving, A | 1 |
| Becouarn, Y; Brunet, R; Calabet, J | 1 |
| Carbone, A; Dal Bo, V; Francini, M; Monfardini, S; Veronesi, A | 1 |
| Dal Bo, V; Francini, M; Galligioni, E; Lo Re, G; Merlo, A; Monfardini, S; Saracchini, S; Sorio, R; Veronesi, A | 1 |
| Dorval, T; Garcia-Giralt, E; Jouve, M; Palangie, T; Pouillart, P | 1 |
| Chasseray, JM; Frydman, R; Paule, B | 1 |
| Bruckman, JE; Burgert, EO; Evans, RG; Gilchrist, GS; Pritchard, DJ; Smithson, WA | 1 |
| Asselain, B; Bretaudeau, B; Garcia-Giralt, E; Jouve, M; Magdelenat, H; Palangie, T; Pouillart, P | 1 |
| Bellamy, AS; Hill, BT | 1 |
| Carter, WH; Stablein, DM; Wampler, GL | 1 |
| Campbell, ED; Carter, WH; Stablein, DM; Wampler, GL | 1 |
| Hofmann, W; Langkopf, B | 1 |
| Abbou, C; Auvert, J; Botto, H; Garcia-Giralt, E; Hannoun, M; Jouve, M; Lachand, AT; Morin, P; Palangie, T; Pouillart, P | 1 |
| Grillot, DA; Nuñez, G; Simonian, PL | 1 |
| Chen, W; Guo, W; Lin, L; Xu, Q; Zhou, X | 1 |
| Chai, H; Li, X; Liu, M; Tang, H; Tian, R | 1 |
4 review(s) available for arginine and fluorouracil
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Advanced malignancy in the young marijuana smoker.
Topics: Adolescent; Adult; Age Factors; Alcohol Drinking; Antineoplastic Combined Chemotherapy Protocols; Arginine; Carcinoma, Squamous Cell; Cisplatin; Cocarcinogenesis; Combined Modality Therapy; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Lip Neoplasms; Male; Marijuana Abuse; Marijuana Smoking; Neck Dissection; Retrospective Studies; Smoking; Tongue Neoplasms; Tonsillar Neoplasms | 1991 |
Role of Nuclear Factor Erythroid 2-Related Factor 2 (NRF-2) Mediated Antioxidant Response on the Synergistic Antitumor Effect of L-Arginine and 5-Fluro Uracil (5FU) in Breast Adenocarcinoma.
Topics: Adenocarcinoma; Animals; Antioxidants; Arginine; Breast Neoplasms; Fluorouracil; Humans; NF-E2-Related Factor 2; Oxidative Stress; Reactive Oxygen Species | 2019 |
Hypersensitivity reactions.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Asparaginase; Aziridines; Benzoquinones; Bleomycin; Chlorambucil; Cisplatin; Cyclophosphamide; Cytarabine; Dacarbazine; Drug Hypersensitivity; Etoposide; Fluorouracil; Humans; Ifosfamide; Melphalan; Methotrexate; Mitomycins; Neoplasms; Paclitaxel; Pentostatin; Procarbazine; Teniposide | 1992 |
4 trial(s) available for arginine and fluorouracil
| Article | Year |
|---|---|
Randomized study of antiinflammatory and immune-modulatory effects of enteral immunonutrition during concurrent chemoradiotherapy for esophageal cancer.
Topics: Adult; Aged; Arginine; C-Reactive Protein; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Enteral Nutrition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Fatty Acids, Omega-3; Female; Fluorouracil; Glutamine; Humans; Immunity, Cellular; Inflammation Mediators; Interferon-gamma; Interleukin-10; Interleukin-6; Male; Middle Aged; Tumor Necrosis Factor-alpha; Young Adult | 2014 |
[Non resectable colonic cancer. Results from a test of chemotherapy with simultaneous prescription of VM26, methyl-CCNU and 5 fluoro-uracile (author's transl)].
Topics: Adult; Aged; BCG Vaccine; Colonic Neoplasms; Drug Therapy, Combination; Female; Fluorouracil; Humans; Immunotherapy; Lomustine; Male; Middle Aged; Nitrosourea Compounds; Podophyllotoxin; Teniposide | 1978 |
Combination chemotherapy of hepatocellular cancer. Comparison of adriamycin + VM 26 + 5-fluorouracil with mAMSA + VM 26 + 5-fluorouracil.
Topics: Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Clinical Trials as Topic; Doxorubicin; Female; Fluorouracil; Humans; Liver Neoplasms; Male; Podophyllotoxin; Random Allocation; Teniposide; Time Factors | 1987 |
[Metastatic breast cancer: controlled trial of chemotherapy with and without hormones].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Mitomycin; Mitomycins; Norethindrone; Tamoxifen; Teniposide; Vincristine | 1984 |
47 other study(ies) available for arginine and fluorouracil
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Isolation of Escherichia coli mutants with changed regulation of uracil uptake.
Topics: Arginine; Biological Transport; Escherichia coli; Fluorouracil; Genes; Mutation; Ornithine Carbamoyltransferase; Streptomycin; Uracil | 1978 |
Infrequently used antidotes: indications and availability.
Topics: Aluminum Compounds; Aluminum Silicates; Aminopropionitrile; Antidotes; Antineoplastic Combined Chemotherapy Protocols; Antivenins; Arginine; Calcium; Carmustine; Ditiocarb; Doxorubicin; Ethanol; Ferrocyanides; Fluorouracil; Glycerides; Humans; Kaolin; Magnesium Compounds; Niacinamide; Penicillamine; Polyethylene Glycols; Silicates; Thioctic Acid | 1986 |
Comparative responses of regulative and determinate embryos to metabolic inhibitors.
Topics: 5-Hydroxytryptophan; Amino Acids; Animals; Antimetabolites; Arginine; Canavanine; Chordata, Nonvertebrate; Dactinomycin; Echinodermata; Embryo, Nonmammalian; Floxuridine; Fluorouracil; In Vitro Techniques; Proteins; Puromycin; RNA; Tryptophan | 1965 |
Assay for AA-tRNA recognition by the EFTu-GTP complex of Escherichia coli.
Topics: Amino Acids; Arginine; Binding Sites; Binding, Competitive; Escherichia coli; Evaluation Studies as Topic; Fluorouracil; Guanosine Triphosphate; Kinetics; Methionine; Methods; Peptide Elongation Factors; Phenylalanine; Protein Binding; RNA, Bacterial; RNA, Transfer; Time Factors; Tryptophan; Valine | 1974 |
Arginine requirement for late mRNA transcription of vaccinia virus in KB cells.
Topics: Arginine; Carbon Isotopes; Carcinoma; Cell Line; Centrifugation, Density Gradient; DNA Replication; DNA, Viral; Fluorouracil; Humans; Mouth Neoplasms; Nucleic Acid Hybridization; RNA, Messenger; Uridine; Vaccinia virus | 1971 |
Effects of 5-fluorouracil on infectious canine hepatitis virus infection of dog kidney cells.
Topics: Animals; Arginine; DNA, Viral; Dogs; Fluorescent Antibody Technique; Fluorouracil; Hemagglutination; Hepatitis Viruses; In Vitro Techniques; Microscopy, Electron; Spectrophotometry | 1966 |
The lethality of streptomycin and the stimulation of RNA synthesis in the absence of protein synthesis.
Topics: Adenine; Arginine; Bacterial Proteins; Carbon Isotopes; Chloramphenicol; Drug Resistance, Microbial; Escherichia coli; Fluorouracil; Guanine; Kanamycin; Neomycin; Phosphates; RNA, Bacterial; Streptomycin; Sulfur Isotopes; Thymine; Uracil | 1966 |
Nuclear histones in Physarum polycephalum during growth and differentiation.
Topics: Amino Acids; Amoeba; Arginine; Cell Differentiation; Cell Nucleus; DNA; DNA Replication; Electrophoresis; Fluorouracil; Histones; Lysine; Mitosis; Myxomycetes; Spores | 1970 |
Inducible synthesis of bacterial luciferase: specificity and kinetics of induction.
Topics: Amines; Amino Acids; Ammonium Chloride; Arginine; Azo Compounds; Bacteria; Bacterial Proteins; Carbamates; Carbon Isotopes; Chloramphenicol; Enzyme Induction; Fluorine; Fluorouracil; Guanidines; Kinetics; Light; Luciferases; Marine Biology; Nitrates; Phenylalanine; Propylamines; Puromycin; RNA, Messenger; Urea | 1967 |
Mechanism of apoptotic effects induced by 5-fluorouracil on human liver carcinoma Bel7402 cell line.
Topics: Antimetabolites, Antineoplastic; Apoptosis; Arginine; Fluorouracil; Humans; Immunohistochemistry; Liver Neoplasms; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Tumor Cells, Cultured | 2002 |
The bulge region of HIV-1 TAR RNA binds metal ions in solution.
Topics: Arginine; Binding Sites; Binding, Competitive; Calcium; Cobalt; Fluorine; Fluorouracil; Gene Products, tat; HIV-1; Humans; Magnesium; Magnetic Resonance Spectroscopy; Metals; Nucleic Acid Conformation; RNA, Viral; tat Gene Products, Human Immunodeficiency Virus | 2002 |
STUDIES ON THE BIOLOGICAL ACTIVITY OF RIBONUCLEIC ACID ISOLATED FROM ESCHERICHIA COLI AFTER EXPOSURE TO 5-FLUOROURACIL.
Topics: Arginine; Escherichia coli; Fluorouracil; Leucine; Metabolism; Pharmacology; Proline; Proteins; Research; RNA; RNA, Bacterial; Serine; Spectrophotometry | 1964 |
Effects of endogenous nitric oxide induced by 5-fluorouracil and L-Arg on liver carcinoma in nude mice.
Topics: Animals; Antimetabolites; Apoptosis; Arginine; bcl-2-Associated X Protein; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p16; Disease Models, Animal; Fluorouracil; Humans; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Nitric Oxide; Nitric Oxide Synthase Type II; Xenograft Model Antitumor Assays | 2007 |
The arginine metabolite agmatine protects mitochondrial function and confers resistance to cellular apoptosis.
Topics: Agmatine; Animals; Antioxidants; Apoptosis; Arginine; Calcium; Camptothecin; Caspase 3; Cell Proliferation; Cytoprotection; DNA Fragmentation; Fluorouracil; Kidney; Membrane Potential, Mitochondrial; Mice; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Mitochondrial Swelling; NIH 3T3 Cells; Polyamines; Proto-Oncogene Proteins c-bcl-2; Rats | 2009 |
[Efficacy of AboundTM for hand-foot syndrome caused by capecitabine].
Topics: Aged; Antimetabolites, Antineoplastic; Arginine; Butyrates; Capecitabine; Deoxycytidine; Female; Fluorouracil; Glutamine; Hand-Foot Syndrome; Humans; Hydroxy Acids; Male; Middle Aged; Neoplasms | 2013 |
Cationic vesicles based on biocompatible diacyl glycerol-arginine surfactants: physicochemical properties, antimicrobial activity, encapsulation efficiency and drug release.
Topics: Anti-Infective Agents; Arginine; Bacteria; Biocompatible Materials; Cations; Chemical Phenomena; Ciprofloxacin; Diglycerides; Drug Liberation; Fluorouracil; Hydrodynamics; Hydrogen-Ion Concentration; Liposomes; Microbial Sensitivity Tests; Particle Size; Static Electricity; Surface-Active Agents | 2014 |
L-arginine pretreatment reduces intestinal mucositis as induced by 5-FU in mice.
Topics: Animals; Antimetabolites, Antineoplastic; Arginine; Fluorouracil; Intestinal Mucosa; Male; Mice; Mucositis; Oxidative Stress; Peroxidase | 2015 |
l-arginine alters the effect of 5-fluorouracil on breast cancer cells in favor of apoptosis.
Topics: Apoptosis; Arginine; Breast Neoplasms; Cell Movement; Cell Survival; Chemokine CXCL12; Female; Fluorouracil; Gene Expression Regulation, Neoplastic; Glucosephosphate Dehydrogenase; Humans; Lactic Acid; MCF-7 Cells; Models, Biological; Neoplasm Invasiveness; Nitric Oxide; Receptors, CXCR4; RNA, Messenger | 2017 |
The Combination of Arginine Deprivation and 5-Fluorouracil Improves Therapeutic Efficacy in Argininosuccinate Synthetase Negative Hepatocellular Carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Arginine; Argininosuccinate Synthase; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Female; Fluorouracil; Gene Expression; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Hydrolases; Liver Neoplasms; Male; Middle Aged; Models, Biological; Polyethylene Glycols; Treatment Outcome | 2017 |
Mathematical modeling of tumor-induced immunosuppression by myeloid-derived suppressor cells: Implications for therapeutic targeting strategies.
Topics: Algorithms; Animals; Antineoplastic Agents; Arginine; Fluorouracil; Humans; Immune Tolerance; Immunity; Killer Cells, Natural; Lymphoma; Mice; Models, Immunological; Myeloid-Derived Suppressor Cells; Neoplasms; T-Lymphocytes, Cytotoxic | 2018 |
Sensitivity of Colorectal Cancer to Arginine Deprivation Therapy is Shaped by Differential Expression of Urea Cycle Enzymes.
Topics: Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Arginase; Arginine; Argininosuccinate Synthase; Cell Line, Tumor; Colon; Colorectal Neoplasms; Drug Interactions; Drug Synergism; Feasibility Studies; Female; Fluorouracil; Follow-Up Studies; Humans; Hydrolases; Inhibitory Concentration 50; Kaplan-Meier Estimate; Male; Mice; Ornithine Carbamoyltransferase; Oxaliplatin; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Treatment Outcome; Urea; Xenograft Model Antitumor Assays | 2018 |
L-arginine/5-fluorouracil combination treatment approaches cells selectively: Rescuing endothelial cells while killing MDA-MB-468 breast cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Arginine; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Female; Fluorouracil; Glycolysis; Human Umbilical Vein Endothelial Cells; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Molecular Docking Simulation; Nitric Oxide; Vascular Endothelial Growth Factor A | 2019 |
Graphene oxide-l-arginine nanogel: A pH-sensitive fluorouracil nanocarrier.
Topics: Arginine; Cell Survival; Fluorouracil; Graphite; Humans; Hydrogen-Ion Concentration; MCF-7 Cells; Nanogels; Nanoparticles; Particle Size; Polyethylene Glycols; Polyethyleneimine; Surface Properties | 2019 |
l-arginine minimizes immunosuppression and prothrombin time and enhances the genotoxicity of 5-fluorouracil in rats.
Topics: Animals; Arginine; Disease Models, Animal; DNA Damage; Female; Fluorouracil; Immunosuppression Therapy; Prothrombin Time; Rats; Rats, Wistar | 2019 |
A modulatory effect of L-arginine supplementation on anticancer effects of chemoimmunotherapy in colon cancer-bearing aged mice.
Topics: Animals; Arginase; Arginine; Colonic Neoplasms; Cyclophosphamide; Dietary Supplements; Fluorouracil; Mice; Oxaliplatin | 2022 |
Association of Fructo-oligosaccharides and Arginine Improves Severity of Mucositis and Modulate the Intestinal Microbiota.
Topics: Animals; Arginine; Fluorouracil; Gastrointestinal Microbiome; Intestinal Mucosa; Intestines; Mice; Mucositis; Oligosaccharides | 2023 |
Multidrug sensitivity phenotype of human lung cancer cells associated with topoisomerase II expression.
Topics: Adenocarcinoma; Antineoplastic Agents; Blotting, Northern; Blotting, Southern; Camptothecin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cell Line; Cell Survival; Cisplatin; DNA Topoisomerases, Type II; DNA, Neoplasm; Doxorubicin; Drug Screening Assays, Antitumor; Etoposide; Fluorouracil; Humans; Lung Neoplasms; Phenotype; Restriction Mapping; RNA, Neoplasm; Teniposide | 1992 |
Increased survival after treatments with anticancer agents of Chinese hamster cells expressing the human Mr 27,000 heat shock protein.
Topics: Animals; Antineoplastic Agents; Arsenic; Arsenites; Blotting, Western; Carmustine; Cell Line; Cell Survival; Colchicine; Cricetinae; Dactinomycin; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance; Etoposide; Fluorouracil; Heat-Shock Proteins; Humans; Hydrogen Peroxide; Pentosyltransferases; Sodium Compounds; Teniposide; Vincristine | 1991 |
Presurgery chemotherapy (CT) in locally advanced bladder carcinoma: a feasible and possibly effective approach.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Doxorubicin; Female; Fluorouracil; Humans; Male; Middle Aged; Preoperative Care; Prospective Studies; Remission Induction; Teniposide; Tomography, X-Ray Computed; Urinary Bladder Neoplasms | 1989 |
Phase II study of a 5-fluorouracil, teniposide and mitomycin-C combination chemotherapy in advanced colorectal carcinomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Colonic Neoplasms; Diarrhea; Drug Evaluation; Fluorouracil; Humans; Mitomycin; Mitomycins; Rectal Neoplasms; Stomatitis; Teniposide | 1988 |
Pre surgery chemotherapy in bladder cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Doxorubicin; Female; Fluorouracil; Humans; Male; Middle Aged; Preoperative Care; Teniposide; Urinary Bladder Neoplasms | 1988 |
Combination chemotherapy with fluorouracil, adriamycin, cis-platinum and VM-26 in advanced transitional cell carcinoma of the urinary tract.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Doxorubicin; Drug Evaluation; Female; Fluorouracil; Humans; Male; Middle Aged; Teniposide; Urologic Neoplasms | 1986 |
[Advanced cancer of the prostate: chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diethylstilbestrol; Doxorubicin; Fluorouracil; Humans; Male; Prostatic Neoplasms; Teniposide | 1986 |
Multimodal approach to the treatment of stage III ovarian carcinoma: preliminary report of a pilot study and critical review.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cystadenocarcinoma; Doxorubicin; Female; Fluorouracil; Humans; Middle Aged; Ovarian Neoplasms; Teniposide | 1985 |
Sequential half-body irradiation (SHBI) and combination chemotherapy as salvage treatment for failed Ewing's sarcoma--a pilot study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carmustine; Child; Fluorouracil; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Palliative Care; Sarcoma, Ewing; Teniposide; Whole-Body Irradiation | 1984 |
Establishment of an etoposide-resistant human epithelial tumour cell line in vitro: characterization of patterns of cross-resistance and drug sensitivities.
Topics: Carcinoma, Squamous Cell; Cell Line; Cisplatin; DNA, Neoplasm; Drug Resistance; Etoposide; Fluorouracil; Humans; Podophyllotoxin; Teniposide; Tongue Neoplasms; Vincristine; X-Rays | 1984 |
Confidence regions for constrained optima in response-surface experiments.
Topics: Antineoplastic Combined Chemotherapy Protocols; Fluorouracil; Humans; Statistics as Topic; Teniposide | 1983 |
Drug activity and therapeutic synergism in cancer treatment.
Topics: Animals; Antineoplastic Agents; Dacarbazine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Female; Fluorouracil; Humans; Hydroxamic Acids; Lung Neoplasms; Male; Melanoma; Mice; Mitomycin; Mitomycins; Neoplasms; Neoplasms, Experimental; Rats; Razoxane; Teniposide | 1982 |
[Possibilities and value of intracavitary and systemic chemotherapy of bladder cancer].
Topics: Antineoplastic Agents; Carcinoma in Situ; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Fluorouracil; Humans; Methotrexate; Mitomycin; Mitomycins; Teniposide; Thiotepa; Urinary Bladder; Urinary Bladder Neoplasms | 1982 |
Combined chemotherapy in the management of metastatic bladder cancer.
Topics: Doxorubicin; Drug Evaluation; Drug Therapy, Combination; Fluorouracil; Humans; Mitomycins; Neoplasm Metastasis; Podophyllotoxin; Teniposide; Urinary Bladder Neoplasms | 1981 |
Bcl-2 and Bcl-XL can differentially block chemotherapy-induced cell death.
Topics: Animals; Antineoplastic Agents; Apoptosis; bcl-X Protein; Clone Cells; Drug Resistance, Neoplasm; Etoposide; Fluorouracil; Gamma Rays; Genes, bcl-2; Humans; Hydroxyurea; Methotrexate; Mice; Proto-Oncogene Proteins c-bcl-2; Recombinant Fusion Proteins; S Phase; Teniposide; Transfection; Vincristine | 1997 |
[Chemosensitivity testing of oral and maxillofacial cancer with biopsy specimens].
Topics: Antineoplastic Agents; Biopsy; Carcinoma, Squamous Cell; Cell Division; Cisplatin; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Fluorouracil; Humans; Maxilla; Maxillary Neoplasms; Mouth; Mouth Neoplasms; Paclitaxel; Teniposide; Tumor Cells, Cultured; Vindesine | 2002 |
miR-20a targets BNIP2 and contributes chemotherapeutic resistance in colorectal adenocarcinoma SW480 and SW620 cell lines.
Topics: Adenocarcinoma; Antineoplastic Agents; Carrier Proteins; Cell Line, Tumor; Colorectal Neoplasms; Drug Resistance, Neoplasm; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs; Organoplatinum Compounds; Oxaliplatin; Teniposide | 2011 |